A study to test how insulin NNC0471-0119 works in the body in participants with type 2 diabetes when given by an insulin pump.
Researchers are conducting an early-stage study to learn more about a new insulin called NNC0471-0119. This study specifically involves individuals living with type 2 diabetes. The main goal is to understand how this new insulin behaves and is processed within the body when it's delivered using an insulin pump. This type of research is an important first step in developing new treatments. It helps scientists gather essential information about how the new insulin affects people, which is crucial before it can be studied in larger groups. Participants will be carefully monitored to see how their bodies react to the insulin and to ensure their safety throughout the study.
De un vistazo
¿De qué trata este estudio?
This study is about a new type of insulin, which has a scientific name: NNC0471-0119. If you have type 2 diabetes, your body either doesn't make enough insulin or doesn't use the insulin it makes very well. Insulin is a hormone that helps your body use sugar for energy. People with type 2 diabetes often need to take extra insulin to manage their blood sugar levels.
In this study, researchers want to see how this new insulin works inside the body when it's given using an insulin pump. An insulin pump is a small device that delivers insulin continuously through a tiny tube placed under the skin. This study is in its very early stages, sometimes called a Phase I study. This means it's one of the first times this new insulin is being tested in people. The main aim is to understand how the body handles the insulin, how much of it gets into the blood, and how long it stays there.
The information gathered from this study is really important. It helps scientists decide if this new insulin is promising enough to be tested in more people and in further studies. This could eventually lead to new and better ways to manage type 2 diabetes in the future.
Puntos clave
- It's an early-stage study (Phase I) for a new insulin.
- The study is for adults with type 2 diabetes.
- It aims to understand how a new insulin works with a pump.
- Both men and women can participate.
- It's a step towards potentially new diabetes treatments.
- Safety and how the body handles the insulin are key focus areas.
¿Quién puede ser elegible?
To be part of this study, you need to be an adult, 18 years old or older. There is no upper age limit, meaning people of any adult age can potentially join.
Both men and women are welcome to take part in this research. The study does not exclude anyone based on their gender.
Crucially, you must have type 2 diabetes to be considered for this study. The researchers will have other specific health requirements, for example, about certain aspects of your diabetes and overall health, to make sure the study is safe and appropriate for you. A medical team will check all these details carefully if you are interested.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes 18 años o más?
- Do you have a diagnosis of type 2 diabetes?
- Are you able to attend study visits regularly?
- Are you generally in good health, apart from your diabetes (as assessed by the study doctor)?
- Are you comfortable potentially using an insulin pump if you don't already?
¿En qué consiste la participación?
Taking part in this study would involve a series of visits to a clinic or research centre. During these visits, you would receive the new insulin (NNC0471-0119) through an insulin pump. The medical team would closely monitor your health, take blood and urine samples, and record how your body reacts to the insulin. You would also have regular health checks and discussions about your well-being. The total duration of your participation, including any follow-up appointments, would be explained in detail before you decide to join.
Riesgos y beneficios potenciales
Ubicaciones (1)
- —No verificadoAlemania
Preguntas comunes
What is an insulin pump?
An insulin pump is a small device that delivers insulin continuously through a thin tube placed under your skin, helping to keep blood sugar levels stable.
Why is this study only for people with type 2 diabetes?
This study specifically focuses on how this new insulin works in individuals whose bodies have type 2 diabetes, which is different from type 1 diabetes.
¿Me pagarán por participar?
The study information available does not specify payment, but compensation for time and travel is common in clinical trials and would be discussed by the research team.
What is 'Phase I' of a clinical trial?
Phase I is an early stage where a new medicine is tested in a small group of people for the first time to check its safety and how it works in the body.
Will this new insulin definitely be available for everyone soon?
No, this is an early study. Many more studies are needed, and there's no guarantee the insulin will be approved for general use. This study is just one step in that process.
Cómo obtener más información
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.